KO
KOO.LSE Kooth plc
- Market cap
- GBX 69.0M
- P/E
- 12.6x
- P/B
- 2.01x
- ROE
- 23.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is KOO.LSE undervalued?
Graham numberKOO.LSE trades 6.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Kooth plc fundamental analysis
No fundamental analysis for Kooth plc yet.
Kooth plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Kooth plc
Kooth plc, together with its subsidiaries, provides digital mental health services to children, young people, and adults in the United Kingdom. It operates online platforms that offers various therapeutic support and interventions, including anonymous and personalized mental health support. The company also operates a community with a library of peer and professional created content, as well as provides online counselling, one-to-one coaching, and support services under the …
Full company profileKooth plc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Kooth plc annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 4.90M | 6.19M | 8.66M | 13.0M | 16.7M | 20.1M | 33.3M | 66.7M | 63.3M | 123M |
| Gross Profit | 2.43M | 3.19M | 4.46M | 7.92M | 11.6M | 13.9M | 25.9M | 52.0M | 40.1M | 79.4M |
| Operating Income | 80.4K | -65.9K | -902K | -1.63M | -733K | -908K | -2.26M | 9.16M | 4.03M | 8.20M |
| EBITDA | 221K | 75.6K | 137K | -133K | 1.65M | 1.32M | 1.51M | 14.5M | 10.2M | 20.2M |
| Net Income | -190K | -234K | -1.08M | -1.48M | -310K | -716K | -169K | 8.03M | 2.61M | 7.94M |
| EPS | -0.01 | -0.01 | -0.03 | -0.04 | -0.01 | -0.02 | 0.00 | 0.21 | 0.07 | 0.21 |
| Balance Sheet | ||||||||||
| Total Assets | 3.73M | 4.83M | 6.38M | 13.5M | 13.8M | 16.1M | 30.7M | 43.0M | 39.3M | 42.4M |
| Total Liabilities | 4.67M | 6.59M | 8.64M | 2.60M | 2.81M | 5.62M | 9.93M | 13.3M | 7.67M | 8.11M |
| Shareholders' Equity | -940K | -1.76M | -2.26M | 10.9M | 11.0M | 10.5M | 20.8M | 29.8M | 31.6M | 34.3M |
| Cash & Short-term Investments | 504K | 389K | 154K | 7.82M | 7.08M | 8.49M | 11.0M | 21.8M | 21.6M | 23.1M |
| Total Debt | 3.63M | 4.56M | 6.46M | 17.0K | - | 68.0K | 44.0K | 23.0K | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 245K | 552K | -80.7K | 360K | 1.85M | 4.43M | 1.87M | 17.1M | 6.27M | 16.4M |
| Capital Expenditure | 937K | 1.54M | 1.02M | 1.61M | 2.60M | 3.05M | 291K | 120K | 72.0K | 332K |
| Free Cash Flow | -691K | -983K | -1.10M | -1.25M | -744K | 1.33M | 1.58M | 17.7M | 6.20M | 16.0M |
| Ratios | ||||||||||
| ROE | - | - | - | -13.6% | -2.8% | -6.8% | -0.8% | 27.0% | 8.3% | 23.1% |
| ROA | -5.1% | -4.8% | -17.0% | -11.0% | -2.2% | -4.4% | -0.6% | 18.7% | 6.6% | 18.7% |
| Net Profit Margin | -3.9% | -3.8% | -12.5% | -11.4% | -1.9% | -3.6% | -0.5% | 12.0% | 4.1% | 6.4% |
| Debt to Equity | - | - | - | 0.00x | - | 0.01x | 0.00x | 0.00x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Kooth plc dividends
Kooth plc has not paid dividends in the last 9 fiscal years.
Who owns Kooth plc
- Insiders 9.36%
- Institutions 67.57%
- Public & others 23.08%
- Shares outstanding 36.4M
- Free float 20.4M
Kooth plc company profile
- Company name
- Kooth plc
- Ticker
- KOO.LSE
- ISIN
- GB00BMCZLK30
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 554
- Fiscal year end
- December
- Address
- 5 Merchant Square, London, United Kingdom, W2 1AY
- Phone
- 44 20 3398 9048
- Website
- koothplc.com
About Kooth plc
Kooth plc, together with its subsidiaries, provides digital mental health services to children, young people, and adults in the United Kingdom. It operates online platforms that offers various therapeutic support and interventions, including anonymous and personalized mental health support. The company also operates a community with a library of peer and professional created content, as well as provides online counselling, one-to-one coaching, and support services under the Kooth, Qwell, and Soluna names. Kooth plc was founded in 2001 and is headquartered in London, United Kingdom.
Kooth plc management
10- Ms. Kate Newhouse M.A.CEO & Executive Director · born 1981
- Mr. Sanjay JawaCFO & Executive Director · born 1965
- Dr. Patrick JohnstonCOO & Executive Director · born 1985
- Kurt SeefeldChief Product & Technology Officer
- Mr. Richard MacmillanHead of Legal and Risk
- Ms. Katherine BeihlChief Marketing Officer
- Siobhan HalfordDirector of People
- Dr. Lynne GreenChief Clinical Officer
- Ms. Bo PengHead of Data Science
- Mr. Fred BendanaChief Commercial Officer